Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • ALTERNATE: Neoadjuvant endocrine treatment (NET) approaches for clinical stage II or Ill estrogen receptor-positive HER2-negative breast cancer (ER+HER2-BC) in postmenopausal (PM) women: Alliance A011106
    Meeting Abstract

    Ma, C. X.; Suman, V. J.; Leitch, A. M.; Sanati, S.; Vij, K. R.; Unzeitig, G. W.; Hoog, J.; Watson, M.; Hahn, O. M.; Guenther, J. M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A phase Ib study to evaluate the oral selective estrogen receptor degrader GDC-9545 alone or combined with palbociclib in metastatic ER-positive HER2-negative breast cancer
    Meeting Abstract

    Lim, E.; Jhaveri, K. L.; Perez-Fidalgo, J. A.; Bellet, M.; Boni, V.; Garcia, J. M. P.; Estevez, L.; Bardia, A.; Turner, N. C.; Villanueva, R.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • MSK-ACCESS for noninvasive somatic mutation profiling of lung cancers utilizing circulating tumor DNA
    Meeting Abstract

    Lebow, E. S.; Murciano-Goroff, Y. R.; Brannon, A. R.; Zehir, A.; Arcila, M. E.; Benayed, R.; Chaft, J. E.; Drilon, A. E.; Kris, M. G.; Gomez, D. R.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Prevalence and clinical characterization of MMR-D/MSI extra-colonic cancers among germline PMS2 mutation carriers
    Meeting Abstract

    Latham, A.; Salo-Mullen, E. E.; Catchings, A.; Ranganathan, M.; Fiala, E.; Kemel, Y.; Konner, J. A.; Soslow, R. A.; Momeni-Boroujeni, A.; Shia, J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Long-term follow-up assessment of cardiac safety in SAFE-HEaRt, a clinical trial evaluating the use of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function
    Meeting Abstract

    Khoury, K.; Barac, A.; Lynce, F.; Geng, X.; Dang, C. T.; Yu, A. F.; Smith, K. L.; Gallagher, C.; Pohlmann, P. R.; Nunes, R.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Independent validation of paige prostate: Assessing clinical benefit of an artificial intelligence tool within a digital diagnostic pathology laboratory workflow
    Meeting Abstract

    Kanan, C.; Sue, J.; Grady, L.; Fuchs, T. J.; Chandarlapaty, S.; Reis-Filho, J. S.; Salles, P. G. O.; da Silva, L. M.; Ferreira, C. G.; Pereira, E. M.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Lipid levels and survival after obesity-related cancer in the Women's Health Initiative CVD biomarker cohort
    Meeting Abstract

    Hovsepyan, G.; Lehman, A.; Thomson, C. A.; Iyengar, N. M.; Beebe-Dimmer, J. L.; Barac, A.; Shadyab, A. H.; Brasky, T.; Saquib, N.; Wild, R.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Genetic testing experiences and emotional reactions among individuals with variant of uncertain significance results from cancer multiplex genetic testing
    Meeting Abstract

    Hamilton, J. G.; Brower, J.; Clark, D.; Ebrahimzadeh, J. E.; Kane, S. R.; Sanchez, P.; Wildman, T.; Merrill, M.; Couch, F.; Garber, J. E.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Phase II trial of bicalutamide in combination with palbociclib for the treatment of androgen receptor (+) metastatic breast cancer
    Meeting Abstract

    Gucalp, A.; Boyle, L. A.; Alano, T.; Arumov, A.; Gounder, M. M.; Patil, S.; Feigin, K.; Edelweiss, M.; D'Andrea, G.; Bromberg, J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Comprehensive breast cancer (BC) risk assessment for CHEK2 carriers incorporating a polygenic risk score (PRS) and the Tyrer-Cuzick (TC) model
    Meeting Abstract

    Gallagher, S.; Hughes, E.; Kurian, A. W.; Domchek, S. M.; Garber, J. E.; Probst, B.; Morris, B.; Tshiaba, P.; Rosenthal, E. T.; Roa, B.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save